This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Dkfz Deutchers Krebsforschungszentrum. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Min Li-Weber: Innovator in Cancer Treatment
Introduction
Min Li-Weber is a notable inventor based in Bad Dürkheim, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the development of combined preparations that enhance the efficacy of cancer therapies.
Latest Patents
Min Li-Weber holds a patent for a groundbreaking invention titled "Combination of rocaglamide and apoptosis inducing substances for the treatment of cancer." This patent describes a combined preparation that includes at least one rocaglamide derivative and at least one apoptosis-inducing agent. The invention aims to improve cancer treatment by utilizing agents that induce the extrinsic apoptotic pathway, antiproliferative agents, and agents that promote apoptosis in T-cells through activation-induced cell death (AICD). He has 1 patent to his name.
Career Highlights
Throughout his career, Min Li-Weber has worked with prestigious institutions such as the Deutsches Krebsforschungszentrum (German Cancer Research Center). His research has contributed to advancements in understanding cancer biology and developing effective treatment strategies.
Collaborations
Min Li-Weber has collaborated with esteemed colleagues in the field, including Peter Krammer and Barbara Leuchs. These collaborations have further enriched his research and contributed to the scientific community's understanding of cancer treatment.
Conclusion
Min Li-Weber's innovative work in cancer treatment exemplifies the impact of research and patents in advancing medical science. His contributions continue to inspire future developments in the fight against cancer.